BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:XB010 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of XB010\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06545331-2807@assetmemo.bio
DTSTAMP:20261121T004043Z
DTSTART;VALUE=DATE:20261123
DTEND;VALUE=DATE:20261124
SUMMARY:XB010: Phase 1 readout est. (NCT06545331)
DESCRIPTION:XB010\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: Study of 
 XB010 in Subjects With Solid Tumors\nEstimated primary completion: 23 Nove
 mber 2026. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/xb010#upco
 ming-events\nRegistry record: https://clinicaltrials.gov/study/NCT06545331
URL:https://assetmemo.bio/drug/xb010#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
